Drug intelligence / Profile preview

Septomida MD

Development stage
Unknown
Lead developer
Laboratorios Viñas
Modality
Small Molecules
Administration
Topical
01

Overview

Septomida MD is a topical astringent and antiseptic treatment developed by Laboratorios Viñas, primarily indicated for the management of exudative (weeping) skin conditions. The product is formulated as a combination of three mineral salts: zinc sulfate, copper sulfate, and potassium aluminum sulfate (alum). Its mechanism of action is based on the astringent properties of these metal salts, which precipitate surface proteins to form a protective layer, constrict tissues, and reduce fluid discharge from skin lesions. Additionally, the copper and zinc components provide mild antimicrobial activity, helping to prevent secondary infections in compromised skin. Septomida MD is commonly used to treat dermatitis, eczema, intertrigo, and superficial skin ulcers, and is available in formats such as powder for solution (sachets) and spray.

Brand names
Septomida MDSeptomida
Other names
zinc sulfate + copper sulfate + potassium aluminum sulfate

Beyond the preview

Go deeper on Septomida MD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septomida MD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call